Seminar on International Arbitration of Life Sciences Disputes

International Arbitration of Life Sciences Disputes: Key Issues and Best Practices

Description: The life sciences industry – pharmaceuticals, medical devices, diagnostics, vaccines, and related businesses – is huge, growing and global, with international licensing, sales contracts, research and development agreements, and joint ventures. Each of these international ventures can lead to disputes, and well-positioned life sciences companies prefer international arbitration to litigation as the practical way to achieve confidential, widely enforceable judgments in a neutral setting. Listen in as our distinguished panel of speakers explain why international arbitration is the preferred dispute resolution mechanism for life sciences disputes, before they take a deeper dive into some of the complex issues that can arise in such disputes. Then join us for a reception following the event.

Location: Boston, MA

Date: April 10, 2019

Time: 5:00- 7:30 PM

Register here :

Staff Contact:   Kendall Thibeadeau

Policy & Program Assistant
Tel: 212.703.5095

As members of USCIB’s Policy Team, Policy and Program Assistants work to support the mission of the organization on an array of issues ranging from Growth, Jobs and Open Market; Competitiveness and Innovation; Sustainable Development; and Business and Society.

Related Content